1. Home
  2. SXT vs HAE Comparison

SXT vs HAE Comparison

Compare SXT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensient Technologies Corporation

SXT

Sensient Technologies Corporation

HOLD

Current Price

$90.68

Market Cap

4.0B

Sector

Industrials

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$83.07

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXT
HAE
Founded
1882
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
SXT
HAE
Price
$90.68
$83.07
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$110.00
$79.67
AVG Volume (30 Days)
283.7K
1.0M
Earning Date
10-31-2025
11-06-2025
Dividend Yield
1.77%
N/A
EPS Growth
56.32
42.54
EPS
3.27
3.44
Revenue
$1,595,084,000.00
$1,327,850,000.00
Revenue This Year
$4.80
N/A
Revenue Next Year
$5.94
$6.01
P/E Ratio
$28.25
$24.43
Revenue Growth
4.25
N/A
52 Week Low
$66.15
$47.32
52 Week High
$121.54
$85.23

Technical Indicators

Market Signals
Indicator
SXT
HAE
Relative Strength Index (RSI) 38.75 84.77
Support Level $92.41 $80.05
Resistance Level $96.77 $85.23
Average True Range (ATR) 2.30 2.05
MACD -0.36 -0.21
Stochastic Oscillator 0.46 82.33

Price Performance

Historical Comparison
SXT
HAE

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: